openPR Logo
Press release

Global Proton Pump Inhibitors (PPI) Market Size, Industry Trends, Share and Forecast 2020-2026

11-20-2020 10:34 AM CET | Health & Medicine

Press release from: ORION MARKET RESEARCH

Global Proton Pump Inhibitors (PPI) Market Size, Industry

The global proton pump inhibitors market is estimated to grow at a CAGR of around 6% during the forecast period. Proton Pump Inhibitors (PPI) is the group of drugs that reduces the risk of gastric acid such as secretion, ulcers and symptoms of gastroesophageal reflux disease in the stomach. Gastroesophageal reflux disease also is known as GERD, is a chronic disease causing problem in the stomach. Additionally, an increase in GERD is due to factors such as tobacco use, obesity and other related problems, this leads to an increase in demand for PPI.

Request a Free Sample of our Global Proton Pump Inhibitors (PPI) Market: https://www.omrglobal.com/request-sample/proton-pump-inhibitors-ppi-market

Furthermore, the digestion problem occurs when acidic intakes such as juices, food and converts into the esophagus. GERD affects all age group people, where people with asthma have a higher risk of developing GERD. In this treatment, the medicines are prescribed orally, in the form of tablets and capsules. Moreover, the increase in the number of peptic ulcers, gastric acid problems and rising demand for novel delivery system accelerating the proton pump inhibitors market growth.
Due to large inclination towards over the counter (OTC) drugs, the market share and growth rate is expected to increase. OTC drugs are the medicines sold directly to consumers without any prescription from healthcare professionals. However, several side effects such as headache, dry mouth, nausea, allergy, diarrhea, kidney-related problems and others related to the treatment hamper the market growth. Apart from this, the diversified market share increases the understanding of various bends that leads to an increase in customer acceptance of esomeprazole drugs is one of the opportunity factors for the PPI market. Apart from this, lack of reach in isolated or remote areas and an increase in consumption of generic drugs can hamper the market growth. However, an increase in demand for novel drugs and introducing new products in the market grab the opportunity factor to increase market growth.

A full Report of Global Proton Pump Inhibitors (PPI) Market is Available at: https://www.omrglobal.com/industry-reports/proton-pump-inhibitors-ppi-market

Global Proton Pump Inhibitors Market Segmentation

By Type

• Esomeprazole
• Omeprazole
• Dexlansoprazole
• Pantoprazole
• Rabeprazole
• Lansoprazole
• Other

By Administration

• Over the Counter
• Prescription

Regional Analysis

• North America
• United States
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World

Company Profiles

• Alkem Laboratories, Ltd.
• AstraZeneca PLC
• Aurobindo Pharma, Ltd.
• Bayer AG
• Cadila Healthcare, Ltd.
• Chongqing LUMMY Pharmaceutical Co., Ltd.
• Eisai Co., Ltd.
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals, Inc.
• Janssen Pharmaceutical, Inc. (A Part ofJohnson & Johnson Service Inc.)
• Lannett Company, Inc.
• Novartis AG
• Pfizer, Inc.
• Procter & Gamble Co.
• Sanofi S.A.
• Sun Pharmaceutical Industries, Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceuticals Industries, Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/proton-pump-inhibitors-ppi-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Proton Pump Inhibitors (PPI) Market Size, Industry Trends, Share and Forecast 2020-2026 here

News-ID: 2191540 • Views:

More Releases from ORION MARKET RESEARCH

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by

All 5 Releases


More Releases for PPI

PPI Market Analysis Current Landscape and Future Outlook
​The global PPI market was valued at approximately USD 4.9 billion in 2023 and is projected to reach around USD 7.73 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2032 . PPI Market Overview The PPI market is experiencing steady growth, driven by the increasing prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The aging global population
PPI Market 2024 Trends, Analysis, Growth, Opportunities, Forecast to 2031
The global proton pump inhibitors market is estimated to grow at a significant CAGR during the forecast period. Many researchers have found that proton pump inhibitors have raised the risk of COVID-19 in patients taking these medications. The researchers of the American Journal of Gastroenterology, in 2020, conducted research in which more than 55,000 people taking proton pump inhibitors participated, out of which 3,476 said that they had tested positive
FSA Gives Banks Extension to Deal with 2011 PPI Claims
The Financial Services Authority (FSA) has given high street banks more time to deal with payment protection insurance (PPI) mis-selling claims. The FSA has given banks Under FSA rules PPI complaints have to be responded to within eight weeks. The extension gives firms time to deal with claims which had been put on hold. It has also given more time for the firms to deal with PPI complaints received since the
PPI Claims Delayed By Banks But This Time The FSA Stand Firm
Many customers will remember with some sorrow the manner in which the bank charges fiasco turned into an ultimately unfortunate defeat for many consumers. The banks halted the stem of complaints by lodging a test case against the Office of Fair Trading and the FSA at the time issued a waiver to allow all bank charges complaints to be kept on hold. In 2010 following countless assessments and investigations, the FSA
Mis-sold PPI - The Worst Personal Finance Scandal Ever?
New information released by the Financial Services Authority (FSA) could see mis-sold PPI become the worst ever personal finance scandal to hit Britain. The FSA believes it will receive 2.75 million complaints about mis-sold PPI over the next five years. Compensation to the customers who have been mis-sold PPI policies is expected to top £4 billion. Could mis-sold PPI become Britain's worst ever personal finance scandal? If the level of complaints
PPI Most Complained About Financial Problem
FOR IMMEDIATE RELEASE London, UK, 16th September, 2010: Payment Protection Insurance (PPI) was the most complained about financial issue in the first half of 2010, according to new figures. The Financial Ombudsman Service (FOS) has received 30,000 complaints from consumers who have been mis-sold the policies. The body received three times more complaints about PPI than the combined totals for mortgages, investments, and pensions. Overall, 84,212 new complaints were made to the FOS about